Company Profiles

driven by the PitchBook Platform

Solace Therapeutics

Description

Developer of non-surgical, office-based treatments for common bladder disorders. The company focuses on treatment of female stress urinary incontinence and overactive bladder (OAB).

2002

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$13M

Latest Deal Amount

$36M

Total Amount Raised

Description

Developer of non-surgical, office-based treatments for common bladder disorders. The company focuses on treatment of female stress urinary incontinence and overactive bladder (OAB).

Website:

www.solacetx.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Other Healthcare Services

Primary Office

135 Newbury Street Framingham, MA 01701United States +1 (508) 283-1200
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Solace Therapeutics's full profile, request a free trial.

Solace Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Solace Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Solace Therapeutics Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Boston ScientificCorporationMinority000 0000000 0000
New Enterprise AssociatesVenture CapitalMinority000 0000000 0000
Saints CapitalSecondary BuyerMinority000 0000000 0000
Spray Venture PartnersVenture CapitalMinority000 0000000 0000
Boston Scientific Corporation
New Enterprise Associates Venture Capital
Saints Capital Secondary Buyer
Spray Venture Partners Venture Capital

Solace Therapeutics Executive Team (5)

NameTitleBoard
Seat
Contact
Info
William GruberPresident, Chief Executive Officer & Board Member
Lisa GruttadauriaController
Bob AlvarezVice President, Engineering
Nicole ShugrueVice President, Marketing
Albert ChinVice President, Research & Development
William Gruber President, Chief Executive Officer & Board Member
Lisa Gruttadauria Controller
Bob Alvarez Vice President, Engineering
Nicole Shugrue Vice President, Marketing
Albert Chin Vice President, Research & Development

Solace Therapeutics Board Members (5)

NameRepresentingRoleSinceContact
Info
Ali Behbahani MDNew Enterprise AssociatesPartner000 0000
John McDonoughSelfBoard Member000 0000
Kevin ConnorsSpray Venture PartnersGeneral Partner & Co-Founder000 0000
Ryan DrantNew Enterprise AssociatesGeneral Partner000 0000
Stacy SengSelfBoard Member000 0000
Ali Behbahani MD Partner New Enterprise Associates
John McDonough Board Member Self
Kevin Connors General Partner & Co-Founder Spray Venture Partners
Ryan Drant General Partner New Enterprise Associates
Stacy Seng Board Member Self
Request full access to PitchBook